Chengdi Yang

1.2k total citations · 1 hit paper
18 papers, 924 citations indexed

About

Chengdi Yang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chengdi Yang has authored 18 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chengdi Yang's work include Genomics, phytochemicals, and oxidative stress (4 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (4 papers). Chengdi Yang is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (4 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (4 papers). Chengdi Yang collaborates with scholars based in China. Chengdi Yang's co-authors include Jun Tao, Xiao Yang, Wenbo Yuan, Haiwei Yang, Jie Han, Pengchao Li, Jingzi Wang, Wei Zhang, Qiang Lv and Li Peng and has published in prestigious journals such as Kidney International, Molecular Cancer and Medicine.

In The Last Decade

Chengdi Yang

18 papers receiving 916 citations

Hit Papers

Circular RNA circ-ITCH inhibits bladder cancer progressio... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression
    2018 398 citations Chengdi Yang, Wenbo Yuan et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengdi Yang China 13 748 603 98 61 55 18 924
Jiangtong Peng China 15 525 0.7× 257 0.4× 86 0.9× 57 0.9× 87 1.6× 23 761
Anqi Li China 12 472 0.6× 296 0.5× 48 0.5× 43 0.7× 94 1.7× 23 685
You Zhou China 12 315 0.4× 193 0.3× 129 1.3× 61 1.0× 54 1.0× 42 653
Biagina Maimone Italy 12 414 0.6× 368 0.6× 57 0.6× 24 0.4× 44 0.8× 14 624
Juan Jin China 10 377 0.5× 323 0.5× 54 0.6× 40 0.7× 27 0.5× 26 527
Jumo Zhu China 8 386 0.5× 219 0.4× 61 0.6× 49 0.8× 112 2.0× 9 524
Qianwei Xing China 14 281 0.4× 149 0.2× 53 0.5× 169 2.8× 28 0.5× 32 483
Pan Tan China 15 408 0.5× 249 0.4× 67 0.7× 36 0.6× 72 1.3× 20 744

Countries citing papers authored by Chengdi Yang

Since Specialization
Citations

This map shows the geographic impact of Chengdi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengdi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengdi Yang more than expected).

Fields of papers citing papers by Chengdi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengdi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengdi Yang. The network helps show where Chengdi Yang may publish in the future.

Co-authorship network of co-authors of Chengdi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Chengdi Yang. A scholar is included among the top collaborators of Chengdi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengdi Yang. Chengdi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Yang, Chengdi, Wenbo Yuan, Xiao Yang, et al.. (2018). Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression. Molecular Cancer. 17(1). 19–19. 398 indexed citations breakdown →
3.
Li, Peng, Xiao Yang, Wenbo Yuan, et al.. (2018). CircRNA-Cdr1as Exerts Anti-Oncogenic Functions in Bladder Cancer by Sponging MicroRNA-135a. Cellular Physiology and Biochemistry. 46(4). 1606–1616. 125 indexed citations
4.
Li, Peng, Xiao Yang, Yidong Cheng, et al.. (2017). MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1. Cellular Physiology and Biochemistry. 41(3). 921–932. 81 indexed citations
5.
Tang, Jingyuan, Zhiqiang Qin, Wei Wang, et al.. (2017). High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma. International Journal of Oncology. 50(5). 1839–1847. 25 indexed citations
6.
Li, Pengchao, Jun Tao, Xiaheng Deng, et al.. (2017). Extraperitoneal Laparoscopic Radical Nephroureterectomy and Lymph Node Dissection in Modified Supine Position. Urology. 107. 126–131. 7 indexed citations
7.
Yang, Xiao, Wenbo Yuan, Jun Tao, et al.. (2017). Identification of circular RNA signature in bladder cancer. Journal of Cancer. 8(17). 3456–3463. 28 indexed citations
8.
Qin, Zhiqiang, Zhen Xu, Ran Li, et al.. (2017). RTA‐408 Protects Kidney from Ischemia‐Reperfusion Injury in Mice via Activating Nrf2 and Downstream GSH Biosynthesis Gene. Oxidative Medicine and Cellular Longevity. 2017(1). 7612182–7612182. 58 indexed citations
9.
Qin, Zhiqiang, Xiao Li, Yuxiao Zheng, et al.. (2017). Association between polymorphic CAG repeat lengths in the androgen receptor gene and susceptibility to prostate cancer. Medicine. 96(25). e7258–e7258. 11 indexed citations
10.
11.
Qin, Zhiqiang, Xiao Li, Yajie Yu, et al.. (2017). Association between PSCA gene polymorphisms and the risk of cancer: an updated meta-analysis and trial sequential analysis. Oncotarget. 8(31). 51766–51778. 5 indexed citations
12.
Qin, Zhiqiang, Chengdi Yang, Ran Li, et al.. (2017). Protective effects of sulforaphane on di-n-butylphthalate-induced testicular oxidative stress injury in male mice offsprings via activating Nrf2/ARE pathway. Oncotarget. 8(47). 82956–82967. 23 indexed citations
13.
Tang, Jingyuan, Zhen Xu, Zhiqiang Qin, et al.. (2017). Sulforaphane attenuates di-N-butylphthalate-induced reproductive damage in pubertal mice: Involvement of the Nrf2-antioxidant system. Environmental Toxicology. 32(7). 1908–1917. 34 indexed citations
14.
Qin, Zhiqiang, Xiao Li, Jianzhong Zhang, et al.. (2016). Chemotherapy with or without estramustine for treatment of castration-resistant prostate cancer. Medicine. 95(39). e4801–e4801. 11 indexed citations
15.
Li, Pengchao, Yidong Cheng, Xiaolei Zhang, et al.. (2016). MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK. OncoTargets and Therapy. Volume 9. 5091–5099. 29 indexed citations
16.
Zhang, Xiaolei, Xiao Yang, Chengdi Yang, et al.. (2016). Targeting protein kinase CK2 suppresses bladder cancer cell survival via the glucose metabolic pathway. Oncotarget. 7(52). 87361–87372. 22 indexed citations
17.
Yang, Xiao, Peng Li, Xiaheng Deng, et al.. (2016). Perioperative treatments for resected upper tract urothelial carcinoma: a network meta-analysis. Oncotarget. 8(2). 3568–3580. 17 indexed citations
18.
Chen, Yueqi, Chengdi Yang, Zhiqin Xie, et al.. (2006). Expression of the novel co-stimulatory molecule B7-H4 by renal tubular epithelial cells. Kidney International. 70(12). 2092–2099. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiangtong Peng Breakdown of academic impact, for papers by Anqi Li Breakdown of academic impact, for papers by You Zhou Breakdown of academic impact, for papers by Biagina Maimone Breakdown of academic impact, for papers by Juan Jin Breakdown of academic impact, for papers by Jumo Zhu Breakdown of academic impact, for papers by Qianwei Xing Breakdown of academic impact, for papers by Pan Tan
Rankless by CCL
2026